NCT01294020View on ClinicalTrials.gov

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 25, 2011

Primary Completion Date

October 25, 2015

Study Completion Date

December 31, 2025

Conditions
Intestine TransplantationKidney TransplantationLung TransplantationLiver TransplantationHeart Transplantation
Interventions
DRUG

Tacrolimus

Oral capsule

DRUG

Tacrolimus prolonged release

Oral capsule

Trial Locations (16)

1020

Site BE21, Brussels

1200

Site BE22, Brussels

24127

Site IT74, Bergamo

69120

Site DE41, Heidelberg

69677

Site FR34, Bron

Site FR35, Bron

75743

Site FR31, Paris

Site FR32, Paris

75908

Site FR33, Paris

90127

Site IT75, Palermo

150 06

Site CZ42, Prague

04-730

Site PL51, Warsaw

Site PL52, Warsaw

B4 6NH

Site GB62, Birmingham

WC1 3JH

Site GB64, London

M27 4HA

Site GB61, Manchester

All Listed Sponsors
lead

Astellas Pharma Europe Ltd.

INDUSTRY